pre-seed
Stage
2
Investors
About
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that creates low-immunogenicity mRNA for therapeutic applications, enabling advanced mRNA therapeutics beyond synthetic mRNA limits.
Explore Sensible Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.